Subsidies & Funding

We empower medical innovation

Project Management

We manage research & innovation projects

Business Strategy

We support successful commercialisation


Audion Therapeutics

ttopstart has partnered with Audion Therapeutics in the first Horizon 2020 full proposal that has been granted.

Audion Therapeutics is a private biopharmaceutical company dedicated to the discovery, development and commercialization of drugs and delivery technologies for the treatment of diseases affecting the ear, including hearing loss.

Our mission is to improve the lives of patients suffering from the most prevalent forms of hearing loss including associated with aging, excessive noise or exposure to ototoxic drugs. Today, about 250 million people suffer from moderate-to-severe or greater hearing loss and this figure doubles when mild hearing loss is included. Yet no drug treatments currently exist.

We are committed to discovering highly effective disease-intervention therapies through our world-leading research into inner ear cellular biology and physiology, and selected partnerships.

Audion Therapeutics is the coordinator of the granted Horizon 2020 project REGAIN on the development of a small drug-molecule to treat hearing loss.

This project had its kick-off in September 2015.